Terms: = Leukemia AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Diagnosis
47 results:
1. Biallelic inactivation of the nf1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.
Ramamoorthy S; Lebrecht D; Schanze D; Schanze I; Wieland I; Andrieux G; Metzger P; Hess M; Albert MH; Borkhardt A; Bresters D; Buechner J; Catala A; De Haas V; Dworzak M; Erlacher M; Hasle H; Jahnukainen K; Locatelli F; Masetti R; Stary J; Turkiewicz D; Vinci L; Wlodarski MW; Yoshimi A; Boerries M; Niemeyer CM; Zenker M; Flotho C
Br J Haematol; 2024 Feb; 204(2):595-605. PubMed ID: 37945316
[TBL] [Abstract] [Full Text] [Related]
2. Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden.
Kampitsi CE; Nordgren A; Mogensen H; Pontén E; Feychting M; Tettamanti G
JAMA Netw Open; 2023 Jul; 6(7):e2325482. PubMed ID: 37490289
[TBL] [Abstract] [Full Text] [Related]
3. Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms.
Calabresi L; Carretta C; Romagnoli S; Rotunno G; Parenti S; Bertesi M; Bartalucci N; Rontauroli S; Chiereghin C; Castellano S; Gentili G; Maccari C; Vanderwert F; Mannelli F; Della Porta M; Manfredini R; Vannucchi AM; Guglielmelli P
Am J Hematol; 2023 Oct; 98(10):1520-1531. PubMed ID: 37399248
[TBL] [Abstract] [Full Text] [Related]
4. [Pheochromocytoma associated with primary hyperparathyroidism and type 1 neurofibromatosis].
Ryabchenko EV; Dremlyuga NV; Mezhinskaya EM; Polyansky EA
Khirurgiia (Mosk); 2023; (7):120-127. PubMed ID: 37379415
[TBL] [Abstract] [Full Text] [Related]
5. [Not Available].
Oliveira AF; Tansini A; Toledo T; Balceiro R; Lee MLM; Villela N; Ikeuty P; Metze K; Lopes LF; Lorand-Metze I
Br J Haematol; 2022 May; 197(3):339-348. PubMed ID: 35187646
[TBL] [Abstract] [Full Text] [Related]
6. Hemophagocytic Lymphohistiocytosis Secondary to Juvenile Myelomonocytic leukemia: A Case Report and Review of the Literature.
Zheng F; Jia Y; Zhang L; Qin J
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e580-e584. PubMed ID: 34862352
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of Gene Mutation and Clinical Characteristics in 19 Children with Juvenile Myelomonocytic leukemia].
Weng KZ; Zheng YZ; Zhuang SQ; Chen HY; LE SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1811-1818. PubMed ID: 33283703
[TBL] [Abstract] [Full Text] [Related]
8. Immunophenotypic characteristics of juvenile myelomonocytic leukaemia and their relation with the molecular subgroups of the disease.
Frisanco Oliveira A; Tansini A; Toledo TR; Balceiro R; Onofre Vidal D; de Martino Lee ML; Lorand-Metze I; Lopes LF
Br J Haematol; 2021 Jan; 192(1):129-136. PubMed ID: 32966606
[TBL] [Abstract] [Full Text] [Related]
9. Estimated number of adult survivors of childhood cancer in United States with cancer-predisposing germline variants.
Wilson CL; Wang Z; Liu Q; Ehrhardt MJ; Mostafavi R; Easton J; Mulder H; Hedges DJ; Wang S; Rusch M; Edmonson M; Levy S; Lanctot JQ; Currie K; Lear M; Patel A; Sapkota Y; Brooke RJ; Moon W; Chang TC; Chen W; Kesserwan CA; Wu G; Nichols KE; Hudson MM; Zhang J; Robison LL; Yasui Y
Pediatr Blood Cancer; 2020 Feb; 67(2):e28047. PubMed ID: 31736278
[TBL] [Abstract] [Full Text] [Related]
10. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
Rokita JL; Rathi KS; Cardenas MF; Upton KA; Jayaseelan J; Cross KL; Pfeil J; Egolf LE; Way GP; Farrel A; Kendsersky NM; Patel K; Gaonkar KS; Modi A; Berko ER; Lopez G; Vaksman Z; Mayoh C; Nance J; McCoy K; Haber M; Evans K; McCalmont H; Bendak K; Böhm JW; Marshall GM; Tyrrell V; Kalletla K; Braun FK; Qi L; Du Y; Zhang H; Lindsay HB; Zhao S; Shu J; Baxter P; Morton C; Kurmashev D; Zheng S; Chen Y; Bowen J; Bryan AC; Leraas KM; Coppens SE; Doddapaneni H; Momin Z; Zhang W; Sacks GI; Hart LS; Krytska K; Mosse YP; Gatto GJ; Sanchez Y; Greene CS; Diskin SJ; Vaske OM; Haussler D; Gastier-Foster JM; Kolb EA; Gorlick R; Li XN; Reynolds CP; Kurmasheva RT; Houghton PJ; Smith MA; Lock RB; Raman P; Wheeler DA; Maris JM
Cell Rep; 2019 Nov; 29(6):1675-1689.e9. PubMed ID: 31693904
[TBL] [Abstract] [Full Text] [Related]
11. Iris juvenile xanthogranuloma in an infant - spontaneous hyphema and secondary glaucoma.
Pantalon A; Ștefănache T; Danciu M; Zurac S; Chiseliță D
Rom J Ophthalmol; 2017; 61(3):229-236. PubMed ID: 29450403
[TBL] [Abstract] [Full Text] [Related]
12. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic leukemia.
Locatelli F; Algeri M; Merli P; Strocchio L
Expert Rev Hematol; 2018 Feb; 11(2):129-143. PubMed ID: 29279013
[TBL] [Abstract] [Full Text] [Related]
13. The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: A retrospective case-control study.
Liy-Wong C; Mohammed J; Carleton A; Pope E; Parkin P; Lara-Corrales I
J Am Acad Dermatol; 2017 Jun; 76(6):1084-1087. PubMed ID: 28189268
[TBL] [Abstract] [Full Text] [Related]
14. Association Between Juvenile Myelomonocytic leukemia, Juvenile Xanthogranulomas and Neurofibromatosis Type 1: Case Report and Review of the Literature.
Paulus S; Koronowska S; Fölster-Holst R
Pediatr Dermatol; 2017 Mar; 34(2):114-118. PubMed ID: 28111791
[TBL] [Abstract] [Full Text] [Related]
15. Humoral immunity to tetanus, measles and rubella in children with acute lymphoblastic leukemia after chemotherapy.
Onorateli M; Botana C; Peralta L; Rebollo M; Ruvinsky S; Guitter M; Felice MS; Posadas M; Evangelista S; Villar MV; Golluscio M; Molina A; Fraquelli L
Arch Argent Pediatr; 2016 Dec; 114(6):549-552. PubMed ID: 27869413
[TBL] [Abstract] [Full Text] [Related]
16. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.
Wimmer K; Rosenbaum T; Messiaen L
Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754
[TBL] [Abstract] [Full Text] [Related]
17. diagnosis and treatment of juvenile myelomonocytic leukemia.
Sakashita K; Matsuda K; Koike K
Pediatr Int; 2016 Aug; 58(8):681-90. PubMed ID: 27322988
[TBL] [Abstract] [Full Text] [Related]
18. [Juvenile myelomonocytic leukemia (JMML): recent advances in molecular pathogenesis and treatment].
Sakashita K
Rinsho Ketsueki; 2016 Feb; 57(2):137-46. PubMed ID: 26935631
[TBL] [Abstract] [Full Text] [Related]
19. Mutation in NRAS in familial Noonan syndrome--case report and review of the literature.
Ekvall S; Wilbe M; Dahlgren J; Legius E; van Haeringen A; Westphal O; Annerén G; Bondeson ML
BMC Med Genet; 2015 Oct; 16():95. PubMed ID: 26467218
[TBL] [Abstract] [Full Text] [Related]
20. The genomic landscape of juvenile myelomonocytic leukemia.
Stieglitz E; Taylor-Weiner AN; Chang TY; Gelston LC; Wang YD; Mazor T; Esquivel E; Yu A; Seepo S; Olsen S; Rosenberg M; Archambeault SL; Abusin G; Beckman K; Brown PA; Briones M; Carcamo B; Cooper T; Dahl GV; Emanuel PD; Fluchel MN; Goyal RK; Hayashi RJ; Hitzler J; Hugge C; Liu YL; Messinger YH; Mahoney DH; Monteleone P; Nemecek ER; Roehrs PA; Schore RJ; Stine KC; Takemoto CM; Toretsky JA; Costello JF; Olshen AB; Stewart C; Li Y; Ma J; Gerbing RB; Alonzo TA; Getz G; Gruber T; Golub T; Stegmaier K; Loh ML
Nat Genet; 2015 Nov; 47(11):1326-1333. PubMed ID: 26457647
[TBL] [Abstract] [Full Text] [Related]
[Next]
